These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36201728)

  • 1. Sources of healthcare-associated Staphylococcus aureus bacteraemia in New Zealand acute hospitals.
    Barratt R; Clendon G; Gibson B; Roberts SA
    N Z Med J; 2022 Oct; 135(1563):29-35. PubMed ID: 36201728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates.
    Kok J; O'Sullivan MV; Gilbert GL
    J Hosp Infect; 2011 Oct; 79(2):108-14. PubMed ID: 21741724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced surveillance of Staphylococcus aureus bacteraemia to identify targets for infection prevention.
    Morris AK; Russell CD
    J Hosp Infect; 2016 Jun; 93(2):169-74. PubMed ID: 27107617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus bacteraemia as a quality indicator for hospital infection control.
    Dendle C; Martin RD; Cameron DR; Grabsch EA; Mayall BC; Grayson ML; Johnson PD
    Med J Aust; 2009 Oct; 191(7):389-92. PubMed ID: 19807631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of Staphylococcus aureus bacteraemia in Israeli children: Community- vs hospital-acquired or healthcare related infections.
    Dabaja-Younis H; Garra W; Shachor-Meyouhas Y; Mashiach T; Geffen Y; Kassis I
    Acta Paediatr; 2021 Jan; 110(1):210-218. PubMed ID: 32506515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare-associated Staphylococcus aureus bacteraemia: time to reduce the harm caused by a largely preventable event.
    Roberts S; Grae N; Muttaiyah S; Morris AJ
    N Z Med J; 2020 Feb; 133(1509):58-64. PubMed ID: 32027639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP) Bloodstream Infection Annual Report 2022.
    Coombs GW; Daley DA; Shoby P; Mowlaboccus S
    Commun Dis Intell (2018); 2023 Nov; 47():. PubMed ID: 37968066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A major reduction in hospital-onset Staphylococcus aureus bacteremia in Australia-12 years of progress: an observational study.
    Mitchell BG; Collignon PJ; McCann R; Wilkinson IJ; Wells A
    Clin Infect Dis; 2014 Oct; 59(7):969-75. PubMed ID: 24973314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and piloting of a prevention assessment and response tool for healthcare-associated Staphylococcus aureus bloodstream infection (the SAB-PART Study) using a Delphi method.
    Karanfilovska D; Cheng AC; Spelman D; Worth LJ
    J Hosp Infect; 2021 Sep; 115():17-26. PubMed ID: 34126103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2020.
    Coombs GW; Daley DA; Yee NWT; Shoby P; Mowlaboccus S
    Commun Dis Intell (2018); 2022 Apr; 46():. PubMed ID: 35469556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP).
    Coombs GW; Daley DA; Shoby P; Mowlaboccus S
    Commun Dis Intell (2018); 2022 Dec; 46():. PubMed ID: 36529133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
    Coombs GW; Daley DA; Lee YT; Pang S
    Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a Victorian statewide surveillance programme to evaluate the burden of healthcare-associated Staphylococcus aureus bacteraemia and Clostridioides difficile infection in patients with cancer.
    Valentine JC; Hall L; Verspoor KM; Gillespie E; Worth LJ
    Intern Med J; 2022 Jul; 52(7):1215-1224. PubMed ID: 33755285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus healthcare associated bacteraemia: An indicator of catheter related infections.
    Bonnal C; Birgand G; Lolom I; Diamantis S; Dumortier C; L'Heriteau F; Armand-Lefevre L; Lucet JC
    Med Mal Infect; 2015 Mar; 45(3):84-8. PubMed ID: 25676476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus bacteraemia of unknown primary source: where do we stand?
    Saginur R; Suh KN
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S21-5. PubMed ID: 18757183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing Staphylococcus aureus bacteremia and sepsis in patients with Staphylococcus aureus colonization of intravascular catheters: a retrospective multicenter study and meta-analysis.
    Hetem DJ; de Ruiter SC; Buiting AGM; Kluytmans JAJW; Thijsen SF; Vlaminckx BJM; Wintermans RGF; Bonten MJM; Ekkelenkamp MB
    Medicine (Baltimore); 2011 Jul; 90(4):284-288. PubMed ID: 21694650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Scottish enhanced Staphylococcus aureus bacteraemia surveillance programme: the first 18 months of data in adults.
    Murdoch F; Danial J; Morris AK; Czarniak E; Bishop JL; Glass E; Imrie LJ
    J Hosp Infect; 2017 Oct; 97(2):133-139. PubMed ID: 28602702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and Mortality of Staphylococcus aureus Bacteremia in Australian and New Zealand Children.
    McMullan BJ; Bowen A; Blyth CC; Van Hal S; Korman TM; Buttery J; Voss L; Roberts S; Cooper C; Tong SY; Turnidge J
    JAMA Pediatr; 2016 Oct; 170(10):979-986. PubMed ID: 27533601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in incidence and resistance patterns of Staphylococcus aureus bacteremia
    Jokinen E; Laine J; Huttunen R; Lyytikäinen O; Vuento R; Vuopio J; Syrjänen J
    Infect Dis (Lond); 2018 Jan; 50(1):52-58. PubMed ID: 29161942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
    Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
    Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.